FDA Warning Letter — Altaire Pharmaceuticals, Inc.

Case 586153 — FEI 1000119582

The FDA took a Warning Letter action against Altaire Pharmaceuticals, Inc. on March 12, 2020 (Aquebogue, NY). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Altaire Pharmaceuticals, Inc.
Date
March 12, 2020
Fiscal Year
2020
Product Type
Drugs
Center
CDER
Location
Aquebogue, NY (United States)